Milestone Pharmaceuticals Inc. Common Shares (MIST)
MIST trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MIST on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | 2019 |
| SEC CIK | 0001408443 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | QC |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. "We believe there are currently no events or conditions that may cast substantial doubt on our ability to continue as a going concern for at least the next 12 months from the date of this filing." | 10-Q 2026-11-13 |
| Cash and burn | $144.5M cash; operating cash flow -$19.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 124,498,693 (2026-11-13); 85,169,344 a year earlier; 33,483,111 three years earlier. | Cover page 2026-11-13 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-05-13 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-10-28 |
| Auditor | PricewaterhouseCoopers LLP, Montreal, Canada | PCAOB Form AP 2026-04-09 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $860K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $3.0M | -$25.8M | -$25.2M | $144.5M | $60.2M | Needs four quarters | 10-Q 2026-11-13 |
| Q2 2026 2026-06-30 | $559K | -$28.6M | -$22.7M | $169.7M | $59.2M | Needs four quarters | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $238K | -$26.1M | -$16.1M | $71.3M | $58.2M | Needs four quarters | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | Not filed | -$17.4M | -$12.8M | $73.0M | $57.2M | Needs four quarters | 10-K 2026-03-20 |
| Q3 2025 2025-09-30 | $0 | -$11.9M | -$9.7M | $46.7M | $56.2M | Needs four quarters | 10-Q 2026-11-13 |
| Q2 2025 2025-06-30 | $0 | -$13.0M | -$12.6M | $42.5M | $55.2M | Needs four quarters | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | $0 | -$20.8M | -$14.0M | $45.1M | $54.3M | Needs four quarters | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | Not filed | -$12.4M | -$6.8M | $25.3M | $53.4M | Needs four quarters | 10-K 2026-03-20 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-05-13 |
| Latest annual report | 10-K | 2026-03-20 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report FORM 8-K | 8-K | 2026-11-13 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 423 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -31.8% |
| 1 month | -32.1% |
| 3 months | -51.4% |
| Year to date | -74.3% |
| 1 year | -72.6% |
| From 52-week high | -82.4% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NMAD | Nomad Power Solutions Inc. | $2.80 | +19.15% | $45.1M |
| RNXT | RenovoRx Inc. | $0.9549 | -8.18% | $46.1M |
| TLPH | Talphera Inc. | $0.8609 | -4.98% | $44.7M |
| HYFT | MindWalk Holdings Corp. | $0.9378 | -8.95% | $44.6M |
| ONCY | Oncolytics Biotech Inc. | $0.3399 | -8.14% | $44.6M |
| ANVS | Annovis Bio Inc. | $0.7500 | -19.02% | $46.5M |
| ATNM | Actinium Pharmaceuticals Inc. (Delaware) | $1.49 | -9.15% | $46.8M |
| PLRX | Pliant Therapeutics Inc. | $0.6932 | -0.55% | $43.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier